Medical News

Exploring the Link between C-Peptide and Vascular Complications in Type-2 Diabetes Patients

A recent large-scale study demonstrated a positive association between C-peptide and cardiovascular disease (CVD) in type-2 diabetes mellitus (T2DM...

17 May, 2019

 
Email this page
Insights from DiRECT: Sustained T2DM Remission at Two-Years Possible with Sustained Weight Loss

A two-year follow-up of the DiRECT program revealed that sustained remissions of type-2 diabetes mellitus (T2DM) at two years was possible in more...

13 May, 2019

 
Email this page
GDM/GH Predict Increased Risk of Postpartum Diabetes and Postpartum Hypertension in Couples as A ‘Unit’

Couples (considered as a unit) with a history of gestational diabetes (GDM) and/or gestational hypertension (GH) are at a greater risk of postpartum...

08 May, 2019

 
Email this page
SGLT2 Inhibitors Prevent further eGFR Decline in T2DM Patients with Advance Renal Dysfunction

A recent study found sodium glucose co-transpporter-2 inhibitors (SGLT2i) to be safe and effective in managing type-2 diabetes mellitus (T2DM)...

06 May, 2019

 
Email this page

Key Trials

SGLT2 Inhibitors for Prevention of CV and Renal Outcomes in T2DM Patients: Does the ASCVD Status Matter?

Findings of the study showed that SGLT2 inhibitors effectively reduce the risk of MACE, renal outcomes, and hospitalizations for HF in T2DM patients...

Regression in Albuminuria is Associated with Reduction in All-Cause Mortality in Insulin-Treated T2DM Patients

This large-scale study reaffirms albuminuria to be an independent marker of subsequent all-cause mortality and cardiovascular events in insulin-...

Sustained Reduction in Incident Diabetes Even 3 Years after Withdrawal of Active SMS-based Lifestyle Intervention

An Indian study demonstrates persistent reduction in risk of T2DM even 3 years after withdrawal of active SMS-based lifestyle intervention.  

Impact of Diabetes on Kidney Function Decline: Results from A 26-year Follow up of Community-based Cohort

The prospective, community-based 26-year follow-up study looks at the impact of diabetes on kidney function decline in a general population.  

Patient Education

Diabetic Retinopathy

Diabetic retinopathy (DR) is the most common and most serious of the ocular complications of diabetes mellitus. This patient education leaflet on DR...

Diabetes Management During Ramadan

Fasting & feasting during Ramadan in diabetes patients is associated with altered glucose level which may lead to low or high blood sugar level....

Know More about Diabetes

Diabetes implies high blood sugar levels in blood. Find out more about the cause, risk factors and complications associated with this disease.

Yoga

The ancient science of yoga provides various health benefits to an individual. Know more about the ‘asanas’ that are beneficial for diabetes patients...

Our Publications

Mind Matters (Issue 3) - Role of Escitalopram in the Treatment of Comorbid Depression and Diabetes

The presence of depression in patients with diabetes mellitus is of vast importance, as it is usually associated with poor disease control, adverse...

Drug Therapy for Management of Hyperglycaemia

Brief information on the treatment strategy and selection of oral antihyperglycemic agents in type 2 diabetes is summarised in this document.

Diabetes Management Series: Cholesterol

Most relevant information on management of dyslipidemia, a common comorbidity observed in diabetes patients, has been summarised in this document.

Diabetes Management Series: Hypertension

Hypertension elevates the risk of micro-and macro-vascular complications in diabetes. Here is a summary on the BP treatment goals in diabetes...

Slide Library

Management of Diabetes during Ramadan

Fasting & feasting during Ramadan in diabetes patients is associated with increased risk of complications such as hypoglycemia, hyperglycemia,...

 
Email this page
Clinical Practice Recommendations: ADA 2014

This slide set summarizes the key 2014 clinical practice recommendations of the American Diabetes Association (ADA) on the screening, diagnosis and...

 
Email this page
Diabetic Dyslipidemia

Dyslipidemia is one of the key risk factors for cardiovascular disease (CVD) in diabetes mellitus. This slide set provides information on the...

 
Email this page
Treating Hypertension in Diabetics : Optimal Selection of Antihypertensive Therapy

Hypertension affects 20%-60% of diabetics. It substantially increases the risk of macrovascular and microvascular complications in diabetes. This...

 
Email this page

Poll

Which is your preferred DPP4 inhibitor for your type 2 diabetes patients with ESRD?
Sitagliptin
21% (4 votes)
Vildagliptin
26% (5 votes)
Linagliptin
47% (9 votes)
No specific choice
5% (1 vote)
Don’t prefer a DPP4 inhibitor
0% (0 votes)
Total votes: 19